SCHEMBL6161597

SCHEMBL6161597

COc1cc(C(=O)O)c(Cl)cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
HTT P42858 2/20 0.49
PYGL P06737 2/20 0.47
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
RECQL P46063 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TPMT P51580 2/20 0.46
PTGS2 P35354 1/20 0.46
CXCL12 P48061 1/20 0.46
ALDH1A1 P00352 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LRRK2 Q5S007 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13434225 0.93 MAPT (0.50) LCKFYNHTTPYGLKDM4E
SCHEMBL2818164 0.86 LCK (0.60) LCKFYNHTTKDM4EMAPT
SCHEMBL10979402 0.85 LCK (0.53) LCKFYNHTTKDM4EMAPT
SCHEMBL11310945 0.85 LCK (0.58) LCKFYNPYGLKDM4EMAPT
SCHEMBL29191828 0.84 LCK (0.57) LCKFYNHTTKDM4EMAPT
SCHEMBL14761140 0.82 HTT (0.57) LCKFYNHTTKDM4EMAPT
SCHEMBL23604246 0.81 LCK (0.50) LCKFYNHTTPYGLKDM4E
SCHEMBL2730020 0.81 ALDH1A1 (0.49) LCKFYNHTTKDM4EMAPT
SCHEMBL15795417 0.80 LCK (0.62) LCKFYNKDM4EMAPTHPGD
SCHEMBL25304441 0.80 PYGL (0.52) LCKFYNHTTPYGLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0920423-B1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH AS (DK) 2005-01-26 EP disclosed
US-6479491-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, ESPECIALLY PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2002-11-12 US disclosed
US-6207662-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2001-03-27 US disclosed
EP-0920423-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1999-06-09 EP disclosed
WO-1998007710-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1998-02-26 WO disclosed